REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Erecept Sp. z o.o. (Poland)

Main Activities: General Medical and Surgical Hospitals
Secondary Activities: Other Information Services | All Other Information Services | Computer Systems Design and Related Services
Full name: Erecept Sp. z o.o. Profile Updated: May 29, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Erecept Sp. z o.o. is an enterprise based in Poland. Its main office is in Gdansk. It operates in the General Medical and Surgical Hospitals industry. The company was established on December 30, 2020. From the latest financial highlights, Erecept Sp. z o.o. reported a net sales revenue increase of 97.28% in 2023. Its’ total assets recorded a growth of 111.52%. The net profit margin of Erecept Sp. z o.o. decreased by 10% in 2023.

Headquarters
Ul. Marii Sklodowskiej-Curie 5
Gdansk; Pomorskie; Postal Code: 80-210

Contact Details: Purchase the Erecept Sp. z o.o. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Erecept Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Erecept Sp. z o.o. report to view the information.
Incorporation Date:
December 30, 2020
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Management Board Member
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Erecept Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
97.28%▲
Total operating revenue
97.28%▲
Operating profit (EBIT)
15.35%▲
EBITDA
15.25%▲
Net Profit (Loss) for the Period
14.6%▲
Total assets
111.52%▲
Total equity
97.09%▲
Operating Profit Margin (ROS)
-10.48%▼
Net Profit Margin
-10%▼
Return on Equity (ROE)
-92.18%▼
Quick Ratio
-2.12%▼
Cash Ratio
-0.36%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo